Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Julphar
Boehringer Ingelheim
Fuji
Mallinckrodt
Novartis
Queensland Health
Covington
Merck
US Army

Generated: January 23, 2018

DrugPatentWatch Database Preview

SODIUM PHOSPHATE P 32 Drug Profile

« Back to Dashboard

When do Sodium Phosphate P 32 patents expire, and what generic alternatives are available?

Sodium Phosphate P 32 is a drug marketed by Mallinckrodt and is included in one NDA.

The generic ingredient in SODIUM PHOSPHATE P 32 is sodium phosphate p-32. There are one thousand four hundred and fifteen drug master file entries for this compound. Additional details are available on the sodium phosphate p-32 profile page.
Summary for SODIUM PHOSPHATE P 32
Drug patent expirations by year for SODIUM PHOSPHATE P 32

US Patents and Regulatory Information for SODIUM PHOSPHATE P 32

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mallinckrodt SODIUM PHOSPHATE P 32 sodium phosphate p-32 SOLUTION;INJECTION, ORAL 011777-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Mallinckrodt SODIUM PHOSPHATE P 32 sodium phosphate p-32 SOLUTION;INJECTION, ORAL 011777-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
QuintilesIMS
Covington
Fish and Richardson
AstraZeneca
Cantor Fitzgerald
Chinese Patent Office
Dow
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot